Shenzhen Sailu Medical Technology

About Shenzhen Sailu Medical Technology

Salus Biomed is a pioneering company in the field of life sciences, specializing in advanced DNA sequencing and spatial omics research tools. The company serves a diverse range of clients, including academic researchers, clinical laboratories, and biotechnology firms. Operating in the rapidly growing genomics and spatial biology markets, Salus Biomed leverages its proprietary Next-Generation Sequencing (NGS) platform and super-resolution imaging techniques to deliver high-performing DNA sequencers and ultra-high resolution spatial omics tools. These products are designed to support both clinical sequencing applications and fundamental spatial omics studies, offering flexible and rapid data output options ranging from 10 to 240G per run. The business model is centered around the sale of these innovative instruments and associated consumables, as well as providing specialized research services. Revenue is generated through direct sales, service contracts, and collaborative research agreements. Salus Biomed's commitment to innovation and collaboration is evident in its multidisciplinary team of experts in engineering, chemistry, molecular biology, and bioinformatics, all working together to unlock new possibilities in life science.